Antimüllerian hormone in polycystic ovarian syndrome: from a key role in the pathogenesis to a sentinel for pre-term birth prediction


Like Comment
Related Content

Volume 113, Issue 2, Pages 335–336


Salvatore Giovanni Vitale, M.D., Ph.D.a, Gaetano Riemma, M.D.b, Antonio Cianci, M.D.a


Reflections on "High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome" by Hu et al.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.